✦ LIBER ✦

Estimating the Probability of Toxicity at the Recommended Dose Following a Phase I Clinical Trial in Cancer

✍ Scribed by John O'Quigley

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Heterogeneity in the definition of dose-

✍ Christophe Le Tourneau; Albiruni R.A. Razak; Hui K. Gan; Simona Pop; Véronique D 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Estimating the safe starting dose in pha

✍ Joseph F. Contrera; Edwin J. Matthews; Naomi L. Kruhlak; R. Daniel Benz 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 491 KB

39A Incorporating toxicity grade informa

✍ Carl A. de Moor; Susan G. Hilsenbeck; Gary M. Clark 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Toxicity profile of the immunomodulatory

✍ R.A. Sharma; W.P. Steward; C.A. Daines; R.D. Knight; K.J. O’Byrne; A.G. Dalgleis 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 153 KB

A Bayesian evaluation of enrolling addit

✍ Mithat Gönen 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 210 KB

The impact of an educational DVD on canc

✍ Elizabeth L. Strevel; Colin Newman; Gregory R. Pond; Martha MacLean; Lillian L. 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 256 KB